Skip to main content
. Author manuscript; available in PMC: 2012 Oct 29.
Published in final edited form as: Urol Oncol. 2009 Dec 4;29(6):670–675. doi: 10.1016/j.urolonc.2009.10.003

Table 4.

Events of grade 3/4 neutropenia and thrombocytopenia which were thought to be possibly or definitely related to treatment

Cohorts
(no.)		 Cycle 1 Cycle 2
Neutropenia Thrombo
cytopenia		 Neutropenia Thrombo
cytopenia
Nadir* Duration (weeks) Events
(duration
of weeks)		 Nadir* Duration (weeks) Events
(duration
of weeks)
1 2 >2 1 2 >2
1 (3) 0.36–0.93   5   1 0 0 0.28–0.55 2 0 0 0
2 (3) 0.35–0.88   4   1 0 0 0.68 1 0 0 0
3 (4) 0.12–0.95   2   4 0 0 0.16–0.59 0 4 0 0
4 (3) 0.08–0.59   3   5 0 0 0.15–0.62 3 1 0 1 (4)
Events 14 11 0 0 6 5 0 1
*

Cells × 103/µl.